TWD 37.6
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 90 Thousand TWD | 217.21% |
2022 | 218.85 Million TWD | 133.88% |
2021 | 93.57 Million TWD | -61.99% |
2020 | 246.16 Million TWD | 98.7% |
2019 | 123.89 Million TWD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 99.77 Million TWD | 77.55% |
2024 Q1 | 55.31 Million TWD | -79.68% |
2023 Q2 | 70.39 Million TWD | -18.1% |
2023 Q4 | 272.27 Million TWD | 0.0% |
2023 Q1 | 85.94 Million TWD | 27.69% |
2023 FY | 694.21 Million TWD | 217.21% |
2023 Q3 | 272.27 Million TWD | 286.81% |
2022 Q3 | 67.31 Million TWD | 0.0% |
2022 FY | 218.85 Million TWD | 133.88% |
2022 Q4 | 67.31 Million TWD | 0.0% |
2021 FY | 93.57 Million TWD | -61.99% |
2020 FY | 246.16 Million TWD | 98.7% |
2019 FY | 123.89 Million TWD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 127.67 Million TWD | 99.93% |
Level Biotechnology Inc. | 151.99 Million TWD | 99.941% |
Sagittarius Life Science Corp | 135.85 Million TWD | 99.934% |
NeoCore Technology Co., Ltd. | 75.85 Million TWD | 99.881% |
TaiMed Biologics Inc. | 225.23 Million TWD | 99.96% |
GlycoNex Incorporation | 995 Thousand TWD | 90.955% |
GeneReach Biotechnology Corp. | 256.86 Million TWD | 99.965% |
Taiwan Advance Bio-Pharmaceutical Inc. | 194.18 Million TWD | 99.954% |
SynCore Biotechnology Co.,Ltd | 46.02 Million TWD | 99.804% |
Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 99.925% |
Visgeneer Inc. | 67.48 Million TWD | 99.867% |
Mycenax Biotech Inc. | -375.19 Million TWD | 100.024% |
Sunmax Biotechnology Co., Ltd. | 510.09 Million TWD | 99.982% |
G&E Herbal Biotechnology Co., Ltd. | 63.9 Million TWD | 99.859% |
Neith Corporation | 66.87 Million TWD | 99.865% |
Medigen Vaccine Biologics Corporation | 1.44 Billion TWD | 99.994% |
TaiwanJ Pharmaceuticals Co., Ltd. | 29.35 Million TWD | 99.693% |
Enimmune corporation | 220.1 Million TWD | 99.959% |
TaiRx, Inc. | 217.13 Million TWD | 99.959% |
EirGenix Inc. | 236.74 Million TWD | 99.962% |
BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 99.914% |
Sunny Pharmtech Inc. | 357.62 Million TWD | 99.975% |
Lin BioScience, Inc. | 1.09 Billion TWD | 99.992% |
BioGend Therapeutics Co., Ltd. | 266.15 Million TWD | 99.966% |
Feng Chi Biotech Corp. | 49.47 Million TWD | 99.818% |
Bio Preventive Medicine Corp. | 1.08 Million TWD | 91.69% |
Lukas Biomedical Inc. | 177.45 Million TWD | 99.949% |
RBC Bioscience Corporation | 58.35 Million TWD | 99.846% |
BiOptic Inc. | 108.69 Million TWD | 99.917% |
Shine-On BioMedical Co.,Ltd. | 69.35 Million TWD | 99.87% |
Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | 96.558% |
VBI | 32.55 Million TWD | 99.724% |
CHO Pharma, Inc. | 268.99 Million TWD | 99.967% |
Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | 72.644% |
Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 99.986% |
Advagene Biopharma Co., Ltd. | 93.33 Million TWD | 99.904% |
NaviFUS Corp. | 11.82 Million TWD | 99.239% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 190.72 Million TWD | 99.953% |
Sinew Pharma Inc. | 186.25 Million TWD | 99.952% |
Andros Pharmaceuticals Co.,Ltd | 74.02 Million TWD | 99.878% |
Greenyn Biotechnology Co., Ltd | 220.39 Million TWD | 99.959% |
Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | 99.783% |
AP Biosciences Inc | 32.25 Million TWD | 99.721% |
Medigen Biotechnology Corp. | 1.85 Billion TWD | 99.995% |
3D Global Biotech Inc. | 5.27 Million TWD | 98.294% |
Pharmosa Biopharm Inc. | 317.32 Million TWD | 99.972% |
Intech Biopharm Corporation | -163.99 Million TWD | 100.055% |
Oneness Biotech Co., Ltd. | 1.12 Billion TWD | 99.992% |
Eusol Biotech Co.,Ltd. | 41.48 Million TWD | 99.783% |
TWi Biotechnology, Inc. | 169.55 Million TWD | 99.947% |
Ever Supreme Bio Technology Co., Ltd | 147.02 Million TWD | 99.939% |
TCI GENE Inc. | 174.61 Million TWD | 99.948% |
MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -400.0% |
Senhwa Biosciences, Inc. | 300.93 Million TWD | 99.97% |
Taiwan Bio Therapeutics Co., Ltd | 290.95 Million TWD | 99.969% |
NatureWise Biotech & Medicals Corporation | 83.94 Million TWD | 99.893% |
PharmaEngine, Inc. | 441.78 Million TWD | 99.98% |
Savior Lifetec Corporation | 223.36 Million TWD | 99.96% |
TaiGen Biopharmaceuticals Holdings Limited | 258.77 Million TWD | 99.965% |
OBI Pharma, Inc. | 2.01 Billion TWD | 99.996% |
Meribank Biotech Co., Ltd | 138.87 Million TWD | 99.935% |
Acepodia, Inc. | 452.56 Million TWD | 99.98% |
Caliway Biopharmaceuticals Co., Ltd. | 540.93 Million TWD | 99.983% |